Kidney Disease

Kidney Disease: Improving Global Outcomes has released a revised clinical practice guideline for the treatment of lupus nephritis.

Researchers identified multiple proteins linked to a higher risk of major cardiovascular events in a study that analyzed blood tests from older adults with kidney disease.

Fresenius Medical Care has received FDA 510(k) clearance for its 5008X Hemodialysis System, allowing for the start of U.S.-based clinical trials, according to a press release.

Kidney Disease: Improving Global Outcomes has released a series of recommendations for the transplant team on how to manage patients with a failing kidney allograft.

Salt substitutes enriched with potassium are a feasible way for people with hypertension to reduce sodium intake long term, yet clinical guidance regarding salt substitute use is lacking, according to a review published in Hypertension.

Kidney dysfunction may play a key role in hospital death and the outcome of thrombolysis in patients who have experienced a stroke, according to a recently published study.

Patients with chronic kidney disease who followed a healthy or overall plant-based diet had a lower risk for all-cause mortality than those who followed an unhealthy plant-based diet, according to recently published data.

Health Canada has approved the use of Jardiance for the treatment of adults with chronic kidney disease, according to a press release.

A chart review completed by Spherix Global Insights shows that more nephrologists are using SGLT2 inhibitors to treat patients with chronic kidney disease, according to a press release.

Novartis has agreed to buy SanReno Therapeutics, a clinical-stage company that specializes in the development of treatments for kidney diseases, according to a press release.